The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum, N Welsh… - PLoS …, 2018 - journals.plos.org
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

Inhibition of NADPH oxidase-1 preserves beta cell function

JR Weaver, W Grzesik, DA Taylor-Fishwick - Diabetologia, 2015 - Springer
Aims/hypothesis Upregulation of the reactive oxygen species (ROS)-producing enzyme
NADPH oxidase (NOX)-1 in islets and beta cells follows acute exposure to inflammatory …

The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice

E Anvari, P Wikström, E Walum, N Welsh - Free radical research, 2015 - Taylor & Francis
In type 2 diabetes, it has been proposed that pancreatic beta-cell dysfunction is promoted by
oxidative stress caused by NADPH oxidase (NOX) overactivity. Five different NOX enzymes …

Phagocyte-like NADPH oxidase [Nox2] in cellular dysfunction in models of glucolipotoxicity and diabetes

A Kowluru, RA Kowluru - Biochemical pharmacology, 2014 - Elsevier
Increased intracellular generation of reactive oxygen species [ROS] has been implicated in
the pathology of metabolic [diabetes] and neurodegenerative [Alzheimer's] diseases …

NADPH Oxidase (NOX) targeting in diabetes: A special emphasis on pancreatic β-cell dysfunction

S Elumalai, U Karunakaran, JS Moon, KC Won - Cells, 2021 - mdpi.com
In type 2 diabetes, metabolic stress has a negative impact on pancreatic β-cell function and
survival (T2D). Although the pathogenesis of metabolic stress is complex, an imbalance in …

NADPH oxidase-2 does not contribute to β-cell glucotoxicity in cultured pancreatic islets from C57BL/6J mice

AH de Souza, LRB Santos, LP Roma… - Molecular and cellular …, 2017 - Elsevier
High glucose-induced oxidative stress and increased NADPH oxidase-2 (NOX2) activity
may contribute to the progressive decline of the functional β-cell mass in type 2 diabetes. To …

Upregulation of phagocyte-like NADPH oxidase by cytokines in pancreatic beta-cells: attenuation of oxidative and nitrosative stress by 2-bromopalmitate

AM Mohammed, K Syeda, T Hadden… - Biochemical …, 2013 - Elsevier
Phagocyte-like NADPH oxidase (Nox2) has been shown to play regulatory roles in the
metabolic dysfunction of the islet β-cell under the duress of glucolipotoxic conditions and …

Suppression of NADPH oxidase 2 substantially restores glucose‐induced dysfunction of pancreatic NIT‐1 cells

H Yuan, Y Lu, X Huang, Q He, Y Man, Y Zhou… - The FEBS …, 2010 - Wiley Online Library
Defects in insulin secretion by pancreatic cells and/or decreased sensitivity of target tissues
to insulin action are the key features of type 2 diabetes. It has been shown that excessive …

NADPH oxidase 2 plays a critical role in dysfunction and apoptosis of pancreatic β-cells induced by very low-density lipoprotein

J Jiao, L Dou, M Li, Y Lu, HB Guo, Y Man… - Molecular and cellular …, 2012 - Springer
In type 2 diabetes, pancreatic β-cells cannot secret enough insulin compensate for insulin
resistance, which are often accompanied by abnormality in lipid metabolism such as …

[HTML][HTML] NSC23766, a known inhibitor of Tiam1-Rac1 signaling module, prevents the onset of type 1 diabetes in the NOD mouse model

R Veluthakal, V Sidarala, A Kowluru - Cellular Physiology and …, 2016 - karger.com
Background/Aims: Type 1 diabetes (T1D) is characterized by absolute insulin deficiency due
to destruction of pancreatic β-cells by cytokines (eg, interleukin-1β; IL-1β) released by …